ストックスクリーナーアプリを入手
26.10
0.65%
0.12
前日終値:
$25.98
開ける：
$25.77
24時間の取引高:
564.74K
Relative Volume:
0.16
時価総額：
$4.83B
収益：
$637.78M
当期純損益:
$239.40M
株価収益率:
21.92
EPS:
1.1909
ネットキャッシュフロー:
$307.21M
1週間 パフォーマンス:
+5.06%
1か月 パフォーマンス:
+24.23%
6か月 パフォーマンス:
-50.40%
1年 パフォーマンス:
-55.82%
1日の値動き範囲:
$25.75
$26.49
1週間の範囲:
$24.54
$26.49
52週間の値動き範囲:
$20.55
$76.51
Doximity Inc Stock (DOCS) Company Profile
名前
Doximity Inc
セクター
電話
(650) 549-4330
住所
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Compare DOCS vs VEEV, BTSG, TEM, HQY
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
26.13 | 4.80B | 637.78M | 239.40M | 307.21M | 1.1909 |
VEEV
Veeva Systems Inc
|
163.72 | 27.15B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
54.37 | 10.63B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
49.07 | 8.95B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
83.49 | 7.17B | 1.31B | 215.20M | 408.32M | 2.4627 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-20 | ダウングレード | Truist | Buy → Hold |
| 2026-04-08 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2026-02-09 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2026-02-06 | アップグレード | JP Morgan | Underweight → Neutral |
| 2026-01-20 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2026-01-09 | 開始されました | RBC Capital Mkts | Outperform |
| 2026-01-08 | アップグレード | Truist | Hold → Buy |
| 2025-12-15 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2025-12-09 | 開始されました | Barclays | Overweight |
| 2025-11-21 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2025-11-13 | 開始されました | BMO Capital Markets | Market Perform |
| 2025-10-27 | アップグレード | BofA Securities | Neutral → Buy |
| 2025-10-10 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2025-10-01 | ダウングレード | Goldman | Neutral → Sell |
| 2025-07-09 | アップグレード | Evercore ISI | In-line → Outperform |
| 2025-06-02 | アップグレード | BTIG Research | Neutral → Buy |
| 2025-02-07 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2025-02-07 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2024-12-20 | 開始されました | Stephens | Equal-Weight |
| 2024-12-04 | 開始されました | Mizuho | Neutral |
| 2024-11-15 | 開始されました | Goldman | Neutral |
| 2024-11-14 | アップグレード | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-13 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2024-11-08 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-11-08 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2024-10-15 | アップグレード | Barclays | Equal Weight → Overweight |
| 2024-08-09 | アップグレード | Needham | Hold → Buy |
| 2024-07-18 | ダウングレード | Wells Fargo | Equal Weight → Underweight |
| 2024-04-25 | アップグレード | JP Morgan | Underweight → Neutral |
| 2024-02-26 | 開始されました | Leerink Partners | Market Perform |
| 2024-01-03 | 開始されました | Barclays | Equal Weight |
| 2024-01-02 | アップグレード | BofA Securities | Underperform → Neutral |
| 2023-08-09 | ダウングレード | Guggenheim | Buy → Neutral |
| 2023-08-09 | ダウングレード | Needham | Buy → Hold |
| 2023-08-03 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2023-05-01 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2023-01-06 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2022-10-31 | 開始されました | Wells Fargo | Overweight |
| 2022-10-24 | 開始されました | Evercore ISI | In-line |
| 2022-10-13 | 開始されました | BTIG Research | Neutral |
| 2022-09-16 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | 開始されました | Truist | Hold |
| 2022-08-05 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2022-07-28 | 開始されました | Berenberg | Buy |
| 2022-05-18 | 繰り返されました | BofA Securities | Neutral |
| 2022-05-18 | 繰り返されました | Goldman | Buy |
| 2022-05-18 | 繰り返されました | Guggenheim | Buy |
| 2022-05-18 | 繰り返されました | Jefferies | Buy |
| 2022-05-18 | 繰り返されました | Morgan Stanley | Equal-Weight |
| 2022-05-18 | 繰り返されました | Needham | Buy |
| 2022-04-07 | 開始されました | Guggenheim | Buy |
| 2022-04-04 | 開始されました | BofA Securities | Neutral |
| 2022-02-11 | 開始されました | Goldman | Buy |
| 2021-12-14 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2021-12-02 | 開始されました | Jefferies | Buy |
| 2021-11-17 | 開始されました | Robert W. Baird | Outperform |
| 2021-11-10 | 繰り返されました | Canaccord Genuity | Buy |
| 2021-11-10 | 繰り返されました | Goldman | Neutral |
| 2021-11-10 | 繰り返されました | Morgan Stanley | Equal-Weight |
| 2021-11-10 | 繰り返されました | Needham | Buy |
| 2021-11-10 | 繰り返されました | Piper Sandler | Overweight |
| 2021-08-26 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2021-07-19 | 開始されました | Canaccord Genuity | Buy |
| 2021-07-19 | 開始されました | Goldman | Neutral |
| 2021-07-19 | 開始されました | JP Morgan | Overweight |
| 2021-07-19 | 開始されました | Morgan Stanley | Equal-Weight |
| 2021-07-19 | 開始されました | Piper Sandler | Overweight |
| 2021-07-19 | 開始されました | Raymond James | Outperform |
| 2021-07-19 | 開始されました | SVB Leerink | Outperform |
| 2021-07-19 | 開始されました | William Blair | Outperform |
すべてを表示
Doximity Inc (DOCS) 最新ニュース
Doximity: Buy Rating Reiterated as Analyst Sees Upside from Depressed Valuation with $49 Price Target Maintained - TipRanks
UBS Group AG Buys 142,408 Shares of Doximity, Inc. $DOCS - MarketBeat
Doximity (DOCS) Soft Guidance and Insider Sales Test the Strength of Its AI Healthcare Story - Yahoo Finance
Doximity (NYSE:DOCS) Director Kira Scherer Wampler Sells 9,000 Shares - MarketBeat
Doximity director Kira Scherer Wampler sells $234,540 of Class A stock - Investing.com UK
Doximity (DOCS) director logs 9,000-share sale and option exercises - Stock Titan
Is Doximity (DOCS) Turning Physician Network Scale Into a Durable AI Platform Advantage? - Sahm
Doximity (DOCS) Q4 2026 Preview: EPS Estimated at $0.28; Reports on May 13 - AlphaStreet
Insights Into Doximity (DOCS) Q4: Wall Street Projections for Key Metrics - Yahoo Finance
Pictet Asset Management Holding SA Sells 735,384 Shares of Doximity, Inc. $DOCS - MarketBeat
Earnings Preview: Doximity to Report Financial Results Post-market on May 13 - Moomoo
Why the Market Dipped But Doximity (DOCS) Gained Today - Yahoo Finance
MSN Money - MSN
DOCS (NYSE: DOCS) files Form 144 to sell 9,000 shares via option - Stock Titan
Doximity Stock Down 40% in 2026: Is the Selloff Building a Multi-Year Entry Opportunity? - TIKR.com
Doximity (DOCS) price target decreased by 31.04% to 44.25 - MSN
Harel Insurance Investments & Financial Services Ltd. Purchases 90,341 Shares of Doximity, Inc. $DOCS - MarketBeat
Doximity (DOCS): Buy, Sell, or Hold Post Q4 Earnings? - Barchart.com
Vanguard Group Inc. Buys 518,916 Shares of Doximity, Inc. $DOCS - MarketBeat
Zacks Industry Outlook Highlights Veeva Systems, Doximity and Omnicell - Yahoo Finance
Doximity, Inc. (DOCS) Stock Analysis: Analyst Ratings Suggest 51% Potential Upside In Healthcare Tech - DirectorsTalk Interviews
Is Doximity, Inc. (DOCS) A Good Stock To Buy Now? - Insider Monkey
Is Doximity (DOCS) a Good Stock to Buy? Bullish Thesis Breakdown - HarianBasis.co
Doximity earnings up next: Can guidance ease valuation pressure? By Investing.com - Investing.com Nigeria
Move Over Doximity — There’s a New Social Network for Doctors - MedCity News
Paul Jorgensen of Doximity Pleads Guilty in $2.5M Insider Trading Case - hannahhowell.com
Assessing Doximity (DOCS) Valuation After Recent Share Price Volatility - Yahoo Finance
JPMorgan Small Cap Equity Fund's Doximity Inc(DOCS) Holding History - GuruFocus
DOCS SEC FilingsDoximity Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Should Doximity’s CFO Transition Before Earnings Require Action From Doximity (DOCS) Investors? - simplywall.st
Vanguard reports 6.79M Doximity shares; Schedule 13G shows 5.07% (DOCS) - Stock Titan
Doximity: Buy It As Mr. Market Is Selling It Cheap Under A Panic Attack (NYSE:DOCS) - Seeking Alpha
Doximity Stock at $25: Priced for Decline or Positioned for a Double-Digit Rebound? - TIKR.com
Is It Too Late To Consider Buying Doximity, Inc. (NYSE:DOCS)? - 富途牛牛
Doximity drops as guidance trails consensus - MSN
Doximity Announces Fiscal 2024 Second Quarter Financial Results - Quantisnow
Doximity (DOCS) Outperforms Broader Market: What You Need to Know - Yahoo Finance
Evercore Maintains Doximity(DOCS.US) With Hold Rating, Maintains Target Price $25 - Moomoo
Doximity, Inc. (DOCS) Stock Analysis: A Look at Its 57% Potential Upside and Strong Buy Sentiment - DirectorsTalk Interviews
Doximity CFO resigns; interim finance head continues - msn.com
Doximity reaches $31M settlement in securities litigation lawsuit - MSN
Evercore ISI Group Maintains Doximity (DOCS) Outperform Recommendation - MSN
Doximity (DOCS) stock dips while market gains: Key facts - MSN
Evercore ISI Group downgrades Doximity (DOCS) - MSN
Victory Sustainable World Fund's Doximity Inc(DOCS) Holding History - GuruFocus
Doximity to Release Fiscal 2026 Fourth Quarter and Full Year Results on May 13, 2026 - The Joplin Globe
Raymond James reiterates Strong Buy on Doximity stock amid OpenAI launch By Investing.com - Investing.com India
VY(R) JPMorgan Small Cap Core Equity Portfolio's Doximity Inc(DOCS) Holding History - GuruFocus
Raymond James reiterates Strong Buy on Doximity stock amid OpenAI launch - Investing.com Australia
Doximity Inc (DOCS) 財務データ
収益
当期純利益
現金流量
EPS
0.62%
1.47%
大文字化:
|
ボリューム (24 時間):